Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease

​OBJECTIVE: Compared with hemoglobin A1c (HbA1c), continuous glucose monitoring (CGM) may better capture risk of diabetes complications in patients with chronic kidney disease (CKD), including diabetic peripheral neuropathy (DPN). We hypothesized that glucose time in range (TIR), measured by CGM, is...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:BMJ Open Diabetes Res Care
Huvudupphovsmän: Mayeda, Laura, Katz, Ronit, Ahmad, Iram, Bansal, Nisha, Batacchi, Zona, Hirsch, Irl B, Robinson, Nicole, Trence, Dace L, Zelnick, Leila, de Boer, Ian H
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2020
Ämnen:
Pathophysiology/Complications
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7039577/
https://ncbi.nlm.nih.gov/pubmed/31958307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000991
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk